242 related articles for article (PubMed ID: 16968413)
1. Cardiovascular pharmacology and physiology of the isoprostanes.
Cracowski JL; Durand T
Fundam Clin Pharmacol; 2006 Oct; 20(5):417-27. PubMed ID: 16968413
[TBL] [Abstract][Full Text] [Related]
2. [Isoprostanes, biomarkers of lipid peroxidation in humans. Part 3: Biomarkers and mediators in vascular physiology and disease].
Cracowski JL; Berdeaux O; Durand T
Pathol Biol (Paris); 2005 Jul; 53(6):364-8. PubMed ID: 16004949
[TBL] [Abstract][Full Text] [Related]
3. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications.
Cracowski JL; Durand T; Bessard G
Trends Pharmacol Sci; 2002 Aug; 23(8):360-6. PubMed ID: 12377577
[TBL] [Abstract][Full Text] [Related]
4. Isoprostanes: an emerging role in vascular physiology and disease?
Cracowski JL
Chem Phys Lipids; 2004 Mar; 128(1-2):75-83. PubMed ID: 15037154
[TBL] [Abstract][Full Text] [Related]
5. F2-isoprostanes biomarkers of lipid peroxidation: their utility in evaluation of oxidative stress induced by toxic agents.
Piłacik B; Nofer TW; Wasowicz W
Int J Occup Med Environ Health; 2002; 15(1):19-27. PubMed ID: 12038860
[TBL] [Abstract][Full Text] [Related]
6. [Isoprostanes, biomarkers of lipid peroxidation in humans. Part 2: Quantification methods].
Berdeaux O; Scruel O; Durand T; Cracowski JL
Pathol Biol (Paris); 2005 Jul; 53(6):356-63. PubMed ID: 16004948
[TBL] [Abstract][Full Text] [Related]
7. [Isoprostanes, biomarkers of lipid peroxidation in humans. Part 1. Nomenclature and synthesis].
Durand T; Cracowski JL; Berdeaux O
Pathol Biol (Paris); 2005 Jul; 53(6):349-55. PubMed ID: 16004947
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid oxidation and isoprostanes: oxidative strain and oxidative stress.
Basu S
Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):219-25. PubMed ID: 20363116
[TBL] [Abstract][Full Text] [Related]
9. F2-isoprostanes as markers of oxidative stress in vivo: an overview.
Milne GL; Musiek ES; Morrow JD
Biomarkers; 2005 Nov; 10 Suppl 1():S10-23. PubMed ID: 16298907
[TBL] [Abstract][Full Text] [Related]
10. Molecular pharmacology of isoprostanes in vascular smooth muscle.
Habib A; Badr KF
Chem Phys Lipids; 2004 Mar; 128(1-2):69-73. PubMed ID: 15037153
[TBL] [Abstract][Full Text] [Related]
11. Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases.
Aviram M
Free Radic Res; 2000 Nov; 33 Suppl():S85-97. PubMed ID: 11191279
[TBL] [Abstract][Full Text] [Related]
12. [Isoprostanes--new possibility of the oxidative stress estimation].
Dołegowska B; Chlubek D
Przegl Lek; 2004; 61(12):1410-4. PubMed ID: 15850339
[TBL] [Abstract][Full Text] [Related]
13. Enzyme immunoassay of isoprostanes.
Callewaert DM; Sloan C
Methods Mol Biol; 2010; 610():435-49. PubMed ID: 20013194
[TBL] [Abstract][Full Text] [Related]
14. Isoprostanes and other markers of peroxidation in atherosclerosis.
Patrignani P; Tacconelli S
Biomarkers; 2005 Nov; 10 Suppl 1():S24-9. PubMed ID: 16298908
[TBL] [Abstract][Full Text] [Related]
15. [Isoprostanes--new markers of oxidative stress].
Staff AC; Halvorsen B
Tidsskr Nor Laegeforen; 2003 Feb; 123(3):315-8. PubMed ID: 12640897
[No Abstract] [Full Text] [Related]
16. [Isoprostanes: a putative key role in vascular diseases].
Cracowski JL
Rev Med Interne; 2004 Jun; 25(6):459-63. PubMed ID: 15158317
[TBL] [Abstract][Full Text] [Related]
17. F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases.
Praticò D; Rokach J; Lawson J; FitzGerald GA
Chem Phys Lipids; 2004 Mar; 128(1-2):165-71. PubMed ID: 15037161
[TBL] [Abstract][Full Text] [Related]
18. In vivo markers of oxidative stress and therapeutic interventions.
Tsimikas S
Am J Cardiol; 2008 May; 101(10A):34D-42D. PubMed ID: 18474272
[TBL] [Abstract][Full Text] [Related]
19. Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress.
Milne GL; Yin H; Brooks JD; Sanchez S; Jackson Roberts L; Morrow JD
Methods Enzymol; 2007; 433():113-26. PubMed ID: 17954231
[TBL] [Abstract][Full Text] [Related]
20. Isoprostanes: are they more than physiopathological biomarkers of lipid peroxidation?
Cracowski JL; Baguet JP
Circulation; 2003 Jun; 107(24):e222; author reply e222. PubMed ID: 12821598
[No Abstract] [Full Text] [Related]
[Next] [New Search]
